ADC Therapeutics SA (ADCT) Q2 2025 Earnings Call Transcript

2025-08-12 11:27:54 ET

ADC Therapeutics SA (ADCT)

Q2 2025 Earnings Conference Call

August 12 2025, 08:30 AM ET

Company Participants

Ameet Mallik - CEO & Director

Jose I. Carmona - Chief Financial Officer

Mohamed Zaki - Chief Medical Officer

Nicole Riley - Corporate Participant

Conference Call Participants

Eric Thomas Schmidt - Cantor Fitzgerald & Co., Research Division

Jenna Li - Jefferies LLC, Research Division

Leonid Timashev - RBC Capital Markets, Research Division

Michael Werner Schmidt - Guggenheim Securities, LLC, Research Division

Sudan Naveen Loganathan - Stephens Inc., Research Division

Presentation

Operator

Good morning, ladies and gentlemen, and welcome to the ADC Therapeutics SA ADCT Q2 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Tuesday, August 12, 2025.

I will now turn the call over to Nicole Riley, Head of Investor Relations and Corporate Communications for ADC Therapeutics. Nicole, please go ahead....

Read the full article on Seeking Alpha

For further details see: